论文部分内容阅读
血管性痴呆患者７８例，随机分为脑通组及尼莫地平组各３９例。脑通组口服脑通１０ｍｇ，３次／ｄ；尼莫地平组口服尼莫地平４０ｍｇ，３次／ｄ，均服用６个月。结果表明，脑通组智力提高和显著提高均优于尼莫地平组
78 patients with vascular dementia were randomly divided into the brain pass group and nimodipine group 39 cases. Naomaitong oral nimotopin 10mg, 3 times / d; Nimodipine group oral nimodipine 40mg, 3 times / d, were taking 6 months. The results showed that brain intelligence group improved significantly and significantly higher than the nimodipine group